Evaluation Of Bronchodilator Use In Copd Patients Using The Atc/Ddd And Du90% Methods At Jember Paru Hospital
DOI:
https://doi.org/10.36858/ipj.v2i2.89Keywords:
COPD, bronchodilator, ATC/DDD, DU90%, drug utilization evaluation.Abstract
Bronchodilators are the primary therapy in the management of COPD; therefore, evaluating their use is crucial to ensure the rationality, safety, and effectiveness of treatment. This study aimed to evaluate bronchodilator use among hospitalized COPD patients at Jember Lung Hospital using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drug Utilization 90% (DU90%) methods. The study employed a non-experimental, quantitative observational design with a retrospective approach. Data were obtained from the medical records of hospitalized COPD patients at Jember Lung Hospital for the period of January–December 2025. The study population consisted of 170 patients, with a sample of 120 patients selected via purposive sampling based on inclusion criteria. Data were analyzed using univariate analysis. The results showed that the patient population was predominantly male (65%) and in the >66 age group (46.67%). Bronchodilators were most frequently administered via the inhalation route (56.84%), with Meprovent being the most commonly prescribed drug (47.54%), followed by Theobron (20.21%) and aminophylline (15.30%). Evaluation using the ATC/DDD method revealed that the Meprovent inhaler had the highest utilization rate, at 59.21 DDD/100 patient-days. Based on the DU90% analysis, the bronchodilators included in the DU90% segment were Meprovent inhaler, oral Theobron, and Farbivent inhaler, whereas intravenous aminophylline, oral Teosal, Spiriva inhaler, Combivent inhaler, and Spiolto inhaler fell into the DU10% segment. The study concludes that the Meprovent inhaler had the highest utilization rate; Meprovent inhaler, oral Theobron, and Farbivent inhaler showed high usage intensity among hospitalized COPD patients.
Keywords: COPD, bronchodilator, ATC/DDD, DU90%, drug utilization evaluation.
References
Agung, A., Putra, N., Prasetya, R., Eka, I. G., Suteja, J., & Marani, P. D. (2023). Evaluation of antibiotic use using ATC/DDD and DU90% methods in pneumonia patients at RSD X, Badung Regency, in 2022. 9(2), 408–418.
Agusti, A., Beasley, R., R. Celli, B., Chen, R., & Criner, G. (2022). GOLD 2022.pdf (pp. 1–22). www.goldcopd.org
Alfaridzi Ibnu Syamsudin. (2022). Analysis of drug compliance factors in hypertension patients at Cilamaya Public Health Center, Karawang Regency. 11, 1651–1658.
Ananda, E., Lilis, A., & Zuhroidah, I. (2025). The relationship between spirituality and quality of life in COPD patients at Citra Husada Hospital, Jember. 4(October), 76–84.
Andriani, Sasmiyanto, & Wahyudi Widada. (2024). Medic Nutricia: Journal of Health Sciences (ISSN: 3025-8855) 2024, Vol. 2, No. 2, 61-75; DOI Prefix 10.5455/mnj.v1i2.644; The relationship between spirituality and quality of life in COPD patients at Citra Husada Hospital, Jember. 2(2). https://doi.org/10.5455/mnj.v1i2.644
Angel, A., Hozefa, H., Susanto, A. D., & Sartika, I. (2025). Jurnal Penelitian Nusantara: The Relationship Between Knowledge Levels and Lifestyle Among Patients with Chronic Obstructive Pulmonary Disease (COPD) at An-Nisa Hospital, Tangerang (2025). Jurnal Penelitian Nusantara, 1(April), 145–149.
Apriliany, W., Pramukantoro, G. E., & Wijayanti, T. (n.d.). Analysis of Antihypertensive Drug Use Among Patients in the Reverse Referral Program (PRB) at a Pharmacy in Regency “A” Using ATC/DDD and DU90% Methods. 10(1), 97–103.
Askar, M., Hammer, T., Henjum, K., & Ioakeim Skoufa. (2023). WHO. www.who.int/teams/health-product-and-policy-standards/inn/atc-ddd
Echazarreta, A., Rahman, M., & Janssens, W. (2025). GOLD 2025.pdf (pp. 1–123). Global Initiative for Chronic Obstructive Lung Disease.
Evaluation of COPD Medication Use Using ATC/DDD and DU90% Methods Among Inpatients at Respira Pulmonary Hospital, Yogyakarta. INDIRA RAHMAWATI, Prof. Dr. apt. Tri Murti Andayani, Sp.FRS. (2024). 0–1.
Hollingworth, S. (2021). Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data. 1–8.
Ihsan. (2021). Analysis of Antibiotic Rationality in Health Service Facilities (Vol. 2).
Kristiningrum, E. (2019). Pharmacotherapy for Chronic Obstructive Pulmonary Disease (COPD). 46(4), 262–271.
Kurniati, A., & Indah Kurniasih, K. (2024). Analysis of Antibiotic Use in Typhoid Fever Patients at Dr. R. Goeteng Taroenadibrata Regional General Hospital (RSUD), Purbalingga, in 2022 Using ATC/DDD and DU90% Methods. Jurnal Kefarmasian Akfarindo, 25–31. https://www.jofar.afi.ac.id/index.php/jofar/article/view/283
Mirza, S., Clay, R. D., Koslow, M. A., & Scanlon, P. D. (2018). COPD Guidelines: A Review of the 2018. Mayo Clinic Proceedings, 93(10), 1488–1502. https://doi.org/10.1016/j.mayocp.2018.05.026
Najihah, Estania Megaputri Theovena, Maria Imaculata Ose, & Donny Tri Wahyudi. (2023). Prevalence of Chronic Obstructive Pulmonary Disease (COPD) Based on Demographic Characteristics and Severity. Journal of Borneo Holistic Health, 6(1), 109–115.
Names, I. N., Substances, P., & Inn, P. (2023). WHO Drug Information (Vol. 37, Issue 2).
PDPI.(2023).COPD. 1–171. https://klikpdpi.com/wp-content/uploads/2025/11/32.-Pedoman-Diagnosis-dan-Penatalaksanaan-PPOK-August-7-2023.pdf
Minister of Health Regulation. (2016). Regulation of the Minister of Health of the Republic of Indonesia. Minister of Health Regulation 2015. (2015). Regulation of the Minister of Health of the Republic of Indonesia.
Permenkes. (2019). Regulation of the Minister of Health of the Republic of Indonesia. 8(5), 55.
Ramadhani, S., Purwono, J., Utami, I. T., Dharma, A. K., & Metro, W. (2022). Application of Pursed-Lip Breathing to Reduce Shortness of Breath in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the Pulmonary Ward of General Hospital (RSUD) Jend. Ahmad Yani, Metro City. Jurnal Cendikia Muda, 2(2), 276–284. https://jurnal.akperdharmawacana.ac.id/index.php/JWC/article/viewFile/347/208
Rokhani, R., Ulfa, M., Narulita, L., Akram, M., et al. (2021). [Study at] RSUD Dr. Slamet Martodirjo Pamekasan Using the ATC/DDD Method. 5(2), 176–184.
Sari, C. P., Hanifah, S., Annisa, Y., et al. (2021). Treatment Effectiveness in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Hospitals in the Yogyakarta Region. 11(4), 215–227. Singh, D., Stockley, R., Anzueto, A., Agusti, A., Bourbeau, J., Celli, B. R., Criner, G. J., Han, M. K., Martinez, F. J., Oca, M. M. De, Ozoh, O. B., Papi, A., Pavord, I., Roche, N., Salvi, S., & Sin, D. D. (2025). GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD. https://doi.org/10.1183/101603-2024
Urip, J., Km, S., Ii, K., Tengah, S., Selatan, K., Tengah, K., & Bar at, K. (2022). Article history: Public Health Faculty; Received in revised form 7 June 2022; Universitas Muslim Indonesia; Accepted 31 July 2022; Available online 25 October 2022. 5(4), 745–751.
Wardiani, Z., Dewi, W. P., Gumilang, S., Salam, F. R., Nurpadilah, A., Ridwan, H., & Ilza, K. (2026). The role of bronchodilator therapy in improving lung function in patients with COPD. 7, 925–934.
Widyaningsih, A., Faradisa, E., & Wijanarko, B. (2024). Keywords: Dyspnea, COPD, Pursed-lip breathing therapy; References: 13 (2018–2024). 1. Journal Article, 13, 1–13.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ayu Putri MS, Adinda Safira
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
